While this outcome is in agreement with previous research that has demonstrated no change in serum oxytocin concentrations following various antidepressant treatments (pharmacological and ECT), in a sample that included both bipolar disorder and MDD [25], it is contrary to some preclinical data. The gene discussed is OXT; the disease is bipolar disorder.